This Plain Language Summary of Publication article (PLSP) from Neurodegenerative Disease Management explains that Alzheimer’s dementia causes declining memory and behavior, with agitation being common. Since people with Alzheimer’s vary in living situations, symptom severity, and other factors, researchers combined data from two clinical studies to examine how brexpiprazole affects agitation across 13 different patient groups with Alzheimer’s dementia.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer’s disease’ and was published in Current Medical Research & Opinion.

Visit Taylor & Francis Online using the link to read the original article.